Forty‐one percent of patients had very long‐chain acyl‐CoA dehydrogenase (VLCAD) deficiency, 54% LCHAD or MTP deficiency, and 5% carnitine palmitoyltransferase 2 (CPT2) deficiency. This evidence concerns the gene ACADVL and abetalipoproteinemia.